Correction to: Analysis of melanoma tumor antigens and immune subtypes for the development of mRNA vaccine

Invest New Drugs. 2022 Dec;40(6):1356. doi: 10.1007/s10637-022-01296-6. Epub 2022 Aug 27.

Haiqin Ping¹, Wenjun Yu¹, Xiaoming Gong¹, Xin Tong¹, Cheyu Lin¹, Zhaojun Chen¹, Caiyun Cai¹, Kai Guo¹, Hengning Ke^{2

3

4}

¹ Department of Infectious Disease, Zhongnan Hospital of Wuhan University, Hubei AIDS Clinical Training Center, Wuhan, People's Republic of China.
² Department of Infectious Disease, Zhongnan Hospital of Wuhan University, Hubei AIDS Clinical Training Center, Wuhan, People's Republic of China. kehengning@znhospital.cn.
³ Wuhan Research Center for Infectious Diseases and Cancer, Chinese Academy of Medical Sciences, Wuhan, People's Republic of China. kehengning@znhospital.cn.
⁴ Cancer Research Institute, General Hospital, Ningxia, Medical University, Yinchuan, People's Republic of China. kehengning@znhospital.cn.

No abstract available

Publication types